ArticleFrontiers in surgery2026
Risk stratification in intermediate asymptomatic carotid artery disease: a multi-modal approach combining local flow dynamics and systemic clinical profiles.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/objectives: Carotid artery stenosis is a leading cause of ischemic stroke, yet accurate patient-specific prediction of its progression remains an unresolved clinical challenge. Neither baseline stenosis severity nor conventional cardiovascular risk factors can reliably identify which asymptomatic patients will progress. This study aimed to develop and validate a machine learning (ML) framework for predicting carotid stenosis progression by integrating patient-specific computational fluid dynamics (CFD) features with clinical and imaging data. Methods: A dataset of 146 carotid arteries from 129 asymptomatic patients enrolled in the multi-center TAXINOMISIS project was used. Stenosis progression was defined as a > 10% increase at the latest available follow-up assessment (56/146 arteries, 38.4%). Twenty-two features were derived from clinical risk factors and CFD-based hemodynamic metrics including time-averaged wall shear stress (TAWSS), oscillatory shear index (OSI), relative residence time (RRT), and disturbed flow indices. ML classifiers were trained using patient-level GroupShuffleSplit, Optuna Bayesian hyperparameter optimization (200 trials), patient-level 5-fold GroupKFold cross-validation, 1,000-iteration bootstrap confidence intervals, and calibration analysis. Performance was benchmarked against two clinically motivated baselines: baseline stenosis grade alone and clinical risk factors alone. Results: The proposed pipeline achieves substantially better discrimination than either clinical baseline: the best-performing model (RF + XGBoost Ensemble, Optuna-tuned) reached AUC=0.814 (95% CI: 0.702-0.917; Sensitivity=0.609; Specificity=0.828; Brier score=0.184), versus AUC=0.552 for stenosis grade alone and AUC=0.459 for clinical risk factors alone - neither of which provides meaningful discrimination. The combined stenosis + clinical model (AUC=0.388) also failed to improve upon either comparator, confirming that hemodynamic information is the necessary added value. Feature contribution analysis consistently identified the normalized area of low TAWSS (Low TAWSS %) as the dominant predictor across all classifiers, followed by the disturbed flow area (LOHA) and vessel-average OSI. Conclusions: A multimodal, physics-informed ML pipeline integrating patient-specific CFD features substantially outperforms all clinical benchmarks for predicting carotid stenosis progression. These findings demonstrate that hemodynamic phenotyping is necessary to advance beyond current risk stratification approaches in asymptomatic carotid disease and support the development of CFD-integrated ML as a clinical decision-support tool in vascular surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.